Pure Global AI
NCT06301269Recruiting

A Study on Self-Compassion,Depression,and Quality of Life Among Primary Caregivers of People With Dementia

National Taiwan University HospitalClinicalTrials.gov
Verified
Study focus
Disease/Condition
Dementia
Study type
Observational
Sponsor & location
Primary sponsor
National Taiwan University Hospital
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Mar 10, 2024
End date
Jul 30, 2024
Enrollment
160 participants
Primary outcome

Self-Compassion Scale,PHQ-9 Scale,Quality-of-Life Scale

Summary

The goal of this observational study is to investigate the correlation between
 self-compassion, depression, and quality of life among primary caregivers of persons with
 dementia.
 
 The main questions it aims to answer are:
 
 1. What is the current status of self-compassion, depression, and quality of life among
 primary caregivers of persons with dementia?
 
 2. Are there differences in self-compassion, depression, and quality of life among primary
 caregivers of persons with dementia based on different background variables?
 
 3. What is the correlation between self-compassion, depression, and quality of life among
 primary caregivers of persons with dementia?
 
 Participants will fill out the questionnaire to complete the study.

ICD-10 classifications
Unspecified dementiaAlzheimer diseaseDementia in Alzheimer diseaseDementia in Alzheimer disease, unspecifiedDementia in other diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06301269
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06301269 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Recruiting. The study focuses on Dementia. Target enrollment is 160 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.